• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑电图能否在 1 周时预测注意缺陷多动障碍对托莫西汀的反应?

Can EEG Predict Response to Atomoxetine in attention deficit hyperactivity disorder at 1 Week?

机构信息

Government Medical College & Hospital, Chandigarh, India.

Panjab University, Chandigarh, India.

出版信息

J Atten Disord. 2021 Mar;25(5):758-767. doi: 10.1177/1087054719829574. Epub 2019 Feb 14.

DOI:10.1177/1087054719829574
PMID:30762472
Abstract

The objective of the study is to predict the early changes in electroencephalography (EEG) at 1 week and its correlation to clinical response at 6 weeks after treatment with atomoxetine in children with ADHD. In 50 children (6-14 years) with ADHD ( [5th ed.; ]), Vanderbilt ADHD Parent Rating Scale (VADPRS) and Vanderbilt ADHD Teachers Rating Scale (VADTRS) were applied at baseline, 1, 4, and 6 weeks. EEG was recorded using International 10-20 System of electrode placement at baseline and at 1 week after atomoxetine treatment. EEG changes at 1 week after atomoxetine therapy was correlated to clinical response at 6 weeks. Patients were classified as responders or nonresponders based on the VADPRS/VADTRS findings. After 1 week of treatment, responders' theta cordance values were decreased, whereas nonresponders' values didn't decrease significantly. Patients with decreased theta cordance values, especially in the left temporoparietal region, at 1 week were likely to respond to atomoxetine while those without any such change were likely to be nonresponders.

摘要

本研究旨在预测 ADHD 儿童接受托莫西汀治疗 1 周时脑电图(EEG)的早期变化及其与 6 周时临床反应的相关性。在 50 名 ADHD 儿童(6-14 岁)中([第 5 版]),在基线、1 周、4 周和 6 周时使用 Vanderbilt ADHD 父母评定量表(VADPRS)和 Vanderbilt ADHD 教师评定量表(VADTRS)进行评估。基线和托莫西汀治疗 1 周后使用国际 10-20 系统电极放置记录 EEG。将托莫西汀治疗 1 周后的 EEG 变化与 6 周时的临床反应相关联。根据 VADPRS/VADTRS 的发现,将患者分为应答者或无应答者。治疗 1 周后,应答者的θ协调值降低,而无应答者的数值没有显著降低。1 周时θ协调值降低的患者,特别是左颞顶叶区域,可能对托莫西汀有反应,而没有任何这种变化的患者可能没有反应。

相似文献

1
Can EEG Predict Response to Atomoxetine in attention deficit hyperactivity disorder at 1 Week?脑电图能否在 1 周时预测注意缺陷多动障碍对托莫西汀的反应?
J Atten Disord. 2021 Mar;25(5):758-767. doi: 10.1177/1087054719829574. Epub 2019 Feb 14.
2
The quantified EEG characteristics of responders and non-responders to long-term treatment with atomoxetine in children with attention deficit hyperactivity disorders.注意缺陷多动障碍儿童中对托莫西汀长期治疗有反应者和无反应者的定量脑电图特征。
Int J Psychophysiol. 2016 Jun;104:44-52. doi: 10.1016/j.ijpsycho.2016.04.004. Epub 2016 Apr 20.
3
Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.患有注意力缺陷多动障碍的年轻成年人对托莫西汀反应的神经生理学预测指标:一项试点项目。
J Psychiatr Res. 2014 Jul;54:11-8. doi: 10.1016/j.jpsychires.2014.03.009. Epub 2014 Mar 27.
4
Effects of Atomoxetine in Individuals with Attention-Deficit/Hyperactivity Disorder and Low-Functioning Autism Spectrum Disorder.托莫西汀对注意力缺陷/多动障碍和低功能自闭症谱系障碍患者的影响。
J Child Adolesc Psychopharmacol. 2016 Nov;26(9):798-806. doi: 10.1089/cap.2015.0179. Epub 2016 May 26.
5
Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.托莫西汀治疗成人注意缺陷/多动障碍患者的功能结局与症状改善之间的关系:综合数据库的事后分析
CNS Drugs. 2016 Jun;30(6):541-58. doi: 10.1007/s40263-016-0346-3.
6
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.在一项为期16周的急性、随机、双盲试验中,托莫西汀改善了患有注意力缺陷多动障碍和阅读障碍的儿童及青少年的注意力。
J Child Adolesc Psychopharmacol. 2013 Nov;23(9):605-13. doi: 10.1089/cap.2013.0054. Epub 2013 Nov 9.
7
A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism.针对自闭症患者注意力缺陷/多动障碍症状及不依从/破坏性行为的家长培训与托莫西汀的1.5年随访
J Child Adolesc Psychopharmacol. 2018 Jun;28(5):322-330. doi: 10.1089/cap.2017.0134. Epub 2018 Apr 25.
8
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.盐酸托莫西汀治疗患有注意力缺陷/多动障碍及共病对立违抗性障碍的儿童和青少年:一项意大利的安慰剂对照研究。
Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008. Epub 2009 Aug 28.
9
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.使用综合数据库对托莫西汀治疗成人注意力缺陷/多动障碍疗效的潜在预测因素进行事后分析。
CNS Drugs. 2016 Apr;30(4):317-34. doi: 10.1007/s40263-016-0323-x.
10
Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review.注意力缺陷多动障碍注意力不集中型和混合型亚型对托莫西汀的反应:一项回顾性病历审查
Atten Defic Hyperact Disord. 2013 Dec;5(4):377-85. doi: 10.1007/s12402-013-0111-0. Epub 2013 Jun 5.

引用本文的文献

1
Translating Decades of Neuroscience Research into Diagnostic and Treatment Biomarkers for ADHD.将数十年的神经科学研究转化为 ADHD 的诊断和治疗生物标志物。
Adv Neurobiol. 2024;40:579-616. doi: 10.1007/978-3-031-69491-2_20.
2
Sub-Scalp Implantable Telemetric EEG (SITE) for the Management of Neurological and Behavioral Disorders beyond Epilepsy.用于管理癫痫以外的神经和行为障碍的头皮下植入式遥测脑电图(SITE)
Brain Sci. 2023 Aug 8;13(8):1176. doi: 10.3390/brainsci13081176.
3
Treatment biomarkers for ADHD: Taking stock and moving forward.
ADHD 的治疗生物标志物:盘点与展望。
Transl Psychiatry. 2022 Oct 12;12(1):444. doi: 10.1038/s41398-022-02207-2.